CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
GROV
Grove Collaborative Holdings, Inc.
There isn't enough reported data to score GROV yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
GROV Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Unavailable |
GROV's profitability and cash flow are currently stable, but its revenue is under pressure. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | โ |
| Current | 35x | $31.89 | โ |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
GROV PE Valuation
GROV has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
GROV Forward outlook
There aren't enough analyst estimates for GROV to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over GROV on earnings quality, reporting a profit while its opponent remains loss making.
GROV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.13 | +$0.49 |
| Q2 2026 | -$0.20 | +$0.38 |
| Q1 2026 | -$0.27 | +$0.49 |
| Q4 2025 | -$0.34 | +$0.42 |
| Q3 2025 | -$0.62 | +$0.05 |
| Q2 2025 | -$0.58 | +$0.36 |
| Q1 2025 | -$0.76 | +$0.22 |
| Q4 2024 | -$0.76 | +$0.52 |
GROV is still losing money, but far less than before: $0.13 per share over the past year, against $1.28 at its worst in late 2023.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over GROV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over GROV on profitability, with a higher operating margin.
GROV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $36.8M | -16% |
| Q2 2026 | $36.6M | -17% |
| Q1 2026 | $36.2M | -17% |
| Q4 2025 | $42.4M | -14% |
| Q3 2025 | $43.7M | -9.4% |
| Q2 2025 | $44M | -15% |
| Q1 2025 | $43.5M | -19% |
| Q4 2024 | $49.5M | -17% |
GROV's revenue has slid since its 2020 peak: $37M last quarter, down 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +6.9 points |
| Q2 2026 | -2.1% | +5.8 points |
| Q1 2026 | -2.5% | +5.6 points |
| Q4 2025 | -3.7% | +13 points |
| Q3 2025 | -6.2% | +7.7 points |
| Q2 2025 | -7.9% | +5.4 points |
| Q1 2025 | -8.1% | -7.1 points |
| Q4 2024 | -17% | -3.6 points |
GROV's operating margin was 0.7% last quarter, up 6.9 points from the same quarter a year ago, near the top of its range since 2020.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
GROV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17K | +$1.2M |
| Q2 2026 | $1.1M | +101% |
| Q1 2026 | -$977K | +$6.4M |
| Q4 2025 | -$62K | +$33K |
| Q3 2025 | -$1.2M | -555% |
| Q2 2025 | $556K | -55% |
| Q1 2025 | -$7.4M | +$5.5M |
| Q4 2024 | -$95K | -119% |
GROV has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
GROV Net Leverage
GROV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
GROV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.8 | Neutral |
| Stochastic | 62.1 | Neutral |
GROV's weekly RSI is 40 (neutral) and its Stochastic is 62 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
GROV PE vs Consumer Defensive Sector
GROV has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over GROV on trend strength, trading above more of its moving averages.
GROV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.04 | 7.7% below |
| 20 week MA | $1.06 | 9.4% below |
| 50 week MA | $1.20 | 20% below |
| 100 week MA | $1.30 | 26% below |
| 200 week MA | $1.60 | 40% below |
GROV is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to โ51% in 2024. It's down 30% so far in 2026.
GROV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $50.0 | $49.4 | -1.3% |
| 2022 | $49.4 | $1.20 | -98% |
| 2023 | $1.20 | $1.77 | +48% |
| 2024 | $1.77 | $1.44 | -19% |
| 2025 | $1.44 | $1.18 | -18% |
| 2026 YTD | $1.18 | $0.96 | -19% |
GROV has the edge over CELH on returns for 2026, with the stronger performance.